Endocyte Receives $75,000,000 New Funding

  • Feed Type
  • Date
    2/4/2011
  • Company Name
    Endocyte
  • Mailing Address
    3000 Kent Avenue West Lafayette, IN 47906
  • Company Description
    Endocyte, Inc, (NASDAQ: ECYT) located in West Lafayette, Indiana, is developing a new generation of receptor-targeted therapeutics or smart drugs for the treatment of cancer and autoimmune diseases.
  • Website
    http://www.endocyte.com
  • Transaction Type
    IPO
  • Transaction Amount
    $75,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy